← Back to Search

Ketone Supplement

Beta-hydroxybutyric acid for Blood Sugar

N/A
Recruiting
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
over the age of 18;
able to fast overnight
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation)
Awards & highlights

Study Summary

This trial is studying the effects of three different ketone supplements on blood ketones and blood sugar levels.

Eligible Conditions
  • Blood Sugar
  • Ketosis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood beta-hydroxybutyrate
Secondary outcome measures
Blood glucose
Blood pressure
Gastrointestinal discomfort
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Beta-hydroxybutyric acidExperimental Treatment1 Intervention
1 x 237 mL
Group II: 1,3-ButanediolExperimental Treatment1 Intervention
1 x 35 mL
Group III: (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoesterActive Control1 Intervention
1 x 20 mL

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,407 Previous Clinical Trials
1,766,537 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Mar 2025